| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/RHEUMATOLOGY/KEL451 |
| P698 | PubMed publication ID | 17255134 |
| P50 | author | Raphaël Porcher | Q38640167 |
| Franck Verrecchia | Q55294513 | ||
| Alain Mauviel | Q67578450 | ||
| P2093 | author name string | Bruneval P | |
| Michel L | |||
| Verola O | |||
| Roos N | |||
| Farge D | |||
| Tiev K | |||
| Ertault M | |||
| Laboureau J | |||
| P2860 | cites work | Deficient Smad7 expression: a putative molecular defect in scleroderma | Q34021184 |
| P433 | issue | 5 | |
| P304 | page(s) | 833-841 | |
| P577 | publication date | 2007-01-25 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Skin involvement in scleroderma--where histological and clinical scores meet | |
| P478 | volume | 46 |
| Q89572849 | Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis |
| Q37987428 | Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases |
| Q47835767 | Assessment of skin involvement in systemic sclerosis |
| Q63214358 | Autologe Stammzelltransplantation bei systemischer Sklerose |
| Q48626265 | Autologous HSCT in systemic sclerosis: a step forward |
| Q37311078 | Autologous stem cell transplantation for systemic sclerosis |
| Q37690672 | B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis |
| Q38771824 | Biomarkers in Scleroderma: Progressing from Association to Clinical Utility |
| Q37905787 | Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling |
| Q28080323 | Cellular Therapies in Systemic Sclerosis: Recent Progress |
| Q37071471 | Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure |
| Q47839424 | Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis |
| Q47321312 | Co-culture of human fibroblasts and Borrelia burgdorferi enhances collagen and growth factor mRNA. |
| Q52613671 | Culture medium and cell density impact gene expression in normal skin and abnormal scar-derived fibroblasts. |
| Q44580937 | Current value of stem-cell transplantation in autoimmune diseases |
| Q36784652 | Cytokine profiles in localized scleroderma and relationship to clinical features |
| Q82256501 | Detection of V, III and I type collagens of dermal tissues in skin lesions of patients with systemic sclerosis and its implication |
| Q46783293 | Dysregulation of angiogenic homeostasis in systemic sclerosis |
| Q34270856 | Emerging targets for the treatment of scleroderma |
| Q37754503 | Evidence of an antifibrotic effect of immunosuppressive drugs: applications in the treatment of systemic sclerosis |
| Q41790850 | Expression of transforming growth factor β receptor II in mesenchymal stem cells from systemic sclerosis patients |
| Q36100604 | Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study. |
| Q36020897 | Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation |
| Q38466458 | Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis |
| Q38004048 | Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option? |
| Q58908910 | Hematopoietic stem cell transplantation for systemic lupus erythematosus |
| Q35925071 | High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study |
| Q54912167 | Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V. |
| Q37022001 | Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis |
| Q28081289 | NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report |
| Q33745028 | PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis |
| Q64276146 | Potential role of CT-textural features for differentiation between viral interstitial pneumonias, pneumocystis jirovecii pneumonia and diffuse alveolar hemorrhage in early stages of disease: a proof of principle |
| Q33665990 | Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis |
| Q47650291 | Self-assessment of skin tightness severity by scleroderma patients |
| Q37265837 | Skin involvement in systemic sclerosis |
| Q43875422 | Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients |
| Q42224815 | Stem cell therapy: resetting autoimmunity or postponing the inevitable? |
| Q33632194 | Stem cell transplantation for autoimmune diseases |
| Q38752477 | The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters |
| Q37586886 | The role of B cells in systemic sclerosis |
| Q35906260 | Transforming growth factor-β increases interleukin-13 synthesis via GATA-3 transcription factor in T-lymphocytes from patients with systemic sclerosis. |
| Q89946091 | Ultrasound Surface Wave Elastography for Assessing Scleroderma |
| Q83188938 | [Systemic sclerosis. Objectives for the treatment] |
Search more.